newsfilter
← Latest News
GlobeNewswire·

Akcea Supports Rare Disease Day 2020 and Global Efforts to “Reframe Rare”

BOSTON, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced the company’s support for Rare Disease...